X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - pathology (1) 1
adult (1) 1
aged (1) 1
amg 102 (1) 1
amplification (1) 1
anthracyclines (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
c-met (1) 1
cancer (1) 1
cancer therapies (1) 1
capecitabine (1) 1
carcinoma (1) 1
circulating level (1) 1
cisplatin - adverse effects (1) 1
cisplatin - therapeutic use (1) 1
confidence intervals (1) 1
contouring (1) 1
delineation (1) 1
deoxycytidine - adverse effects (1) 1
deoxycytidine - analogs & derivatives (1) 1
deoxycytidine - therapeutic use (1) 1
didactic (1) 1
disease-free survival (1) 1
dose-response relationship, drug (1) 1
double-blind method (1) 1
drug administration schedule (1) 1
drug therapy (1) 1
e-learning (1) 1
epirubicin - adverse effects (1) 1
epirubicin - therapeutic use (1) 1
esophagogastric junction - drug effects (1) 1
esophagogastric junction - pathology (1) 1
expression (1) 1
female (1) 1
fluorouracil - adverse effects (1) 1
fluorouracil - analogs & derivatives (1) 1
fluorouracil - therapeutic use (1) 1
gene amplification (1) 1
hematology, oncology and palliative medicine (1) 1
hepatocellular carcinoma (1) 1
hepatocyte growth-factor (1) 1
humans (1) 1
index medicus (1) 1
liver cancer (1) 1
male (1) 1
maximum tolerated dose (1) 1
medical prognosis (1) 1
metastasis (1) 1
middle aged (1) 1
monoclonal antibodies (1) 1
monoclonal-antibody (1) 1
neoplasm invasiveness - pathology (1) 1
neoplasm staging (1) 1
oncology (1) 1
patients (1) 1
pharmacokinetics (1) 1
prognosis (1) 1
proportional hazards models (1) 1
radiation oncology (1) 1
radiation therapy (1) 1
radiotherapy volumes (1) 1
stomach cancer (1) 1
stomach neoplasms - drug therapy (1) 1
stomach neoplasms - mortality (1) 1
stomach neoplasms - pathology (1) 1
survival rate (1) 1
thrombosis (1) 1
treatment outcome (1) 1
tumors (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 1007 - 1018
Summary Background Dysregulation of the hepatocyte growth factor (HGF)/MET pathway promotes tumour growth and metastasis. Rilotumumab is a fully human,... 
Hematology, Oncology and Palliative Medicine | AMPLIFICATION | PHARMACOKINETICS | ONCOLOGY | HEPATOCYTE GROWTH-FACTOR | C-MET | MONOCLONAL-ANTIBODY | CIRCULATING LEVEL | AMG 102 | CANCER | EXPRESSION | CARCINOMA | Confidence Intervals | Adenocarcinoma - pathology | Esophagogastric Junction - drug effects | Prognosis | Capecitabine | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Stomach Neoplasms - pathology | Dose-Response Relationship, Drug | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Fluorouracil - adverse effects | Neoplasm Invasiveness - pathology | Adult | Deoxycytidine - adverse effects | Female | Double-Blind Method | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Proportional Hazards Models | Esophagogastric Junction - pathology | Survival Rate | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Maximum Tolerated Dose | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Epirubicin - therapeutic use | Aged | Neoplasm Staging | Stomach Neoplasms - mortality | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Epirubicin - adverse effects | Monoclonal antibodies | Anthracyclines | Index Medicus
Journal Article
Journal of Cancer Education, ISSN 0885-8195, 2018, pp. 1 - 7
Radiation therapy (RT) is an effective treatment modality for hepatocellular carcinoma (HCC), but globally, it is underutilized. In Russia, practice patterns... 
Contouring | e-learning | Didactic | Radiation oncology | Delineation | Hepatocellular carcinoma | Radiotherapy volumes | Liver cancer | Patients | Radiation therapy
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.